Jan Schernthaner

Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa

F. Lottspeich, W. Mewes, T. Karl, 2021, Skin Pharmacology and Physiology.

RiboScreenTM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin

M. Rinnerthaler, T. Karl, C. Gerner, 2024, International journal of molecular sciences.